Assertio Holdings | DEPO - Gross Profit On Sales

Stock Price
18.01
Daily Change
-0.01 -0.06%
Monthly
31.65%
Yearly
101.96%
Q2 Forecast
17.53

Assertio Holdings reported $22.24M in Gross Profit on Sales for its fiscal quarter ending in June of 2024.





Gross Profit On Sales Change Date
ANI Pharmaceuticals USD 124.18M 12.39M Dec/2025
Assertio Holdings USD 22.24M 970K Jun/2024
Aurora Cannabis CAD 46.62M 14.33M Dec/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Daiichi Sankyo JPY 439.83B 95.05B Dec/2025
Ironwood Pharmaceuticals USD 85.24M 44.1M Jun/2025
J&J USD 16.6B 118M Dec/2025
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Merck USD 13.42B 431M Sep/2025
Nektar Therapeutics USD 21.81M 8.06M Dec/2025
Omeros USD -33.16M 18.52M Jun/2024
Pfizer USD 3.54B 7.61B Sep/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025